COVID-19 variant boosters won't need new clinical trials for clearance, FDA says - The Verge

The FDA will rely on data from clinical trials of COVID-19 vaccine boosters against the BA.1 version of the omicron variant to evaluate boosters against the BA.4 and BA.5 variants.

The agency will use data from earlier booster trials Illustration by Alex Castro / The Verge COVID-19 vaccine manufacturers wont need to conduct new clinical trials as they develop booster shots ta… [+1432 chars]

full article...